Prior to his career in venture, Adam was a Postdoctoral Fellow of Neuroscience at Weill Cornell Medical College, researching regenerative stem cell medicine in association with brain disorders such as schizophrenia and Alzheimer’s disease.

Fascinated with the potential of digitization in life sciences and the broader healthcare ecosystem, Adam has invested in companies that span the realms of virtual clinical trials and real world evidence platforms to single particle tracking microscopy drug discovery companies.

Adam Goulburn is the co-founder and Managing Partner of Dimension, a $300 million fund focused on investing in companies at the intersection of medicine and data science. New VC Firm Dimension Gets $350 Million as Healthcare Venture Fundraising Remains High. Three venture investors weigh in on the future of biotech as they launch a new $350M fund.

2023年1月25日 · That’s why Dar has left his previous firm, Lux Capital, to join forces with fellow former Lux alumnus Adam Goulburn and Obvious Ventures alumnus Nan Li. In March 2022, the three created a brand...

2023年2月2日 · Dimension 的三位创始人 Adam Goulburn、Zavain Dar 和 Nan Li 是领域内经验丰富的投资新秀，他们在生物技术和计算科学领域创建和投资公司上具有独到见解，也颇有成果。 创始人 Adam Goulburn 和 Zavain Dar 曾经都是 Lux Capital 的普通合伙人。

2023年1月25日 · The firm is led by former Lux general partners Adam Goulburn and Zavain Dar, as well as ex-Obvious Ventures managing director Nan Li. At Lux, Goulburn and Dar backed tech-powered biotech startups like Eikon Therapeutics, Kallyope and Recursion Pharmaceuticals.

Adam Goulburn is the Founder & Managing Partner at Dimension Capital. Additionally, Adam Goulburn has had 6 past jobs including Partner at Lux Capital. Adam Goulburn holds 4 board and advisor roles including Board Member at CareGuardian, Board Member at Science 37, and Mentor at Healthbox.

Dr. Adam Goulburn is a Co-Founder of Cajal Neuroscience. He serves as Board Member at Kimia Therapeutics. He is a Co-Founder and serves as Managing Partner at Dimension. He is the Founding Partner of Dimension (Consulting Services). He served as …

2017年8月29日 · How did get your start in the venture capital community? It was a non-obvious path. I actually came through the research academic route. I have a PhD in stem cell biology and was researching at...